Forecast: Import of Ambergris, Civet, Musk for Pharmaceutical Use to the UK

The import value of ambergris, civet, and musk for pharmaceutical use to the UK is forecasted to grow steadily from 2024 to 2028. In 2023, the actual import value was lower than the projected figures for 2024, indicating a positive growth trend.

- **2024 to 2028 Outlook**: A consistent annual increase in value is evident, with the import forecast to rise from $707.77k in 2024 to $741.82k by 2028. This suggests a growing demand in the UK pharmaceutical sector for these components.

- **Year-on-Year Variation (2024-2028)**: The annual growth rate averages approximately 1.19%, signifying steady expansion in the market. Each year approximates to a similar growth rate, reflecting a stable upward trajectory.

- **CAGR Analysis (2024-2028)**: The compound annual growth rate over the five years would be indicative of a moderate and sustainable market expansion.

In future trends, factors to monitor include price variations influenced by supply chain dynamics, regulatory changes impacting imports, and potential shifts in consumer preferences towards synthetic alternatives. These could significantly influence the market dynamics beyond 2028.